---
bio-current:
  name-cn: 弗朗西斯卡·米赫尔
  name-en: Franziska Michor
  email: 
    - fmichor@hsph.harvard.edu # 如果有多个邮箱，请都填写上
  sex: female
  birth-date: # yyyy 到年即可
  university: Harvard University 
  school: Dept, of Biostatistics [https://www.hsph.harvard.edu/biostatistics] # 格式：学院名称[学院官网链接]
  major: Computational Biology and Biostatistics
  title-raw: Professor # 主页原始字符串
  title: Professor
  interests: 
    - Mathematical Model 
    - Mutation 
    - Cancer 
    - Genetics 
    - Bioinformatics # 分点罗列，依次以 ‘-’ 开头
  homepage: 
    - https://www.hsph.harvard.edu/franziska-michor/
    - http://michorlab.dfci.harvard.edu/index.php/people/franziska-michor
    - http://michorlab.dfci.harvard.edu/ # 如果有多个主页，请都填写上
  github: 
  googlescholar: https://scholar.google.com/citations?hl=zh-CN&user=2oXpzgQAAAAJ 
  aminer: https://www.aminer.cn/profile/michor-franziska/5633c74945cedb339abf66c8 # 从这里查找 https://www.aminer.org/search/person
  status: 在职
  last-update: 2021-09-01 # yyyy-mm-dd 最近一次信息更新日期
edu-phd:  # 读博经历
  university: Harvard University
  school: Evolutionary Dynamics of Cancer
  email: 
  date-start: 
  date-end: 2005
  advisor: # 格式：导师名 [邮箱/网址]
  degree: # phd
edu-master: # 硕士经历，没有或找不到，可不填
  university: 
  school: 
  date-start: 
  date-end: 
  advisor:
edu-bachelor:  # 本科经历，没有或找不到，可不填
  university: 
  school: 
  major: 
  date-start: 
  date-end: 
page-other:   # 其他有用的链接，部分可从学者主页子栏目获得
  publication: https://connects.catalyst.harvard.edu/Profiles/display/Person/94293
  research: https://connects.catalyst.harvard.edu/Profiles/display/Person/94293
  software: 
  project: 
  blog: 
  arxiv: 
  linkedin: 
  weibo:
  twitter:
  wikipedia:
  baidu-baike:
collaboration: # 合作研究，关注学者和其他哪些学科的人合作，具体研究哪些主题
  - 
    with: # 合作者
    project: # 研究主题
  - 
    with: 
    project: 
group: # 所属团队，学者可能有不同的兴趣小组，可以列上去
job-faculty-1: # 所属机构，若有多个增加编号即可，字段填写参看示例文件
  university: Harvard University 
  school: Dept, of Biostatistics [https://www.hsph.harvard.edu/biostatistics] 
  major: Computational Biology and Biostatistics
  email: fmichor@hsph.harvard.edu
  homepage: https://www.hsph.harvard.edu/franziska-michor/ # 机构内学者主页
  date-start: 
  title: Professer
  type: 
job-post-doc: # 博士后研究员，字段填写参看示例文件，若无可不填写
  university: 
  school: 
  email: 
  date-start: 
  date-end: 
  advisor: 
---

# Profile

![Franziska Michor](https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=1240520)

# Biography[English]

Dr. Michor is a Professor of Computational Biology in the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute, in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health, and in the Department of Stem Cells and Regenerative Biology at Harvard University. Dr. Michor obtained her undergraduate training in mathematics and molecular biology from the University of Vienna, Austria, and her PhD from the Department of Organismic and Evolutionary Biology at Harvard University. Afterwards, she was awarded a fellowship from the Harvard Society of Fellows. From 2007 until 2010, she was an Assistant Professor in the Computational Biology Program at Memorial Sloan-Kettering Cancer Center. Dr. Michor is the director of the Dana-Farber Cancer Institute Physical Sciences-Oncology Center and the Center for Cancer Evolution. She has been the recipient of the Theodosius Dobzhansky Prize of the Society for the Study of Evolution, the Alice Hamilton Award , the Vilcek Prize for Creative Promise in Biomedical Science, the 36th Annual AACR Award for Outstanding Achievement in Cancer Research, and others. Dr. Michor's laboratory investigates the evolutionary dynamics of cancer initiation, progression, response to therapy, and emergence of resistance.

# Biography[中文]

# Interests[English]

* Mathematical Model 
* Mutation 
* Cancer 
* Genetics 
* Bioinformatics

# Interests[中文]

# Education[English]

- **2000 - 2002**	Undergraduate studies at the University of Vienna (molecular biology and mathematics)
- **2002**	Università degli Studi di Trieste, Italy (medical biotechnology)
- **2002**	First Diploma (Bachelor of Science) from the University of Vienna
- **2002 - 2003**	Institute for Advanced Study, Program in Theoretical Biology
- **2003 - 2005**	Graduate studies at Harvard University in the Department of Organismic and Evolutionary Biology
- **2005**	PhD from Harvard University (Thesis: Evolutionary Dynamics of Cancer )

# Education[中文]

# Awards[English]

- Prize of the Austrian Mathematical Society for the paper 
The Mathematics of Planetary Movement, 2000
- Harold M. Weintraub Graduate Student Award of the
Fred Hutchinson Cancer Research Center, Seattle, Washington, 2004
- Junior Fellowship of the Harvard Society of Fellows, 2005-2008
- Theodosius Dobzhansky Prize of the Society for the Study of Evolution, 2007
- ASCINA Award (Austrian Scientists and Scholars in North America), 2008
- Leon Levy Foundation Young Investigator Award, 2009
- Gerstner Young Investigator Award, 2010
- Alice Hamilton Award, 2012
- Vilcek Prize for Creative Promise in Biomedical Science, 2015
- NYSCF - Robertson Stem Cell Prize, 2015
- The 36th Annual AACR Award for Outstanding Achievement in Cancer Research, 2016

# Awards[中文]

# Talks[English]

# Talks[中文]

# Work experience[English]

**2005 - 2007**	**Junior Fellow in the Harvard Society of Fellows**
**2007 - 2010**	**Assistant Professor at Memorial Sloan-Kettering Cancer Center**
**2008 - 2010**	**Adjunct Assistant Professor at Weill Cornell Graduate School of Medical Sciences**
**2010 - 2014** **Associate Professor in the Department of Data Science, Dana-Farber Cancer Institute and the Department of Biostatistics, Harvard T.H. Chan School of Public Health**
**2015 -** **Professor in the Department of Data Science, Dana-Farber Cancer Institute and the Department of Biostatistics, Harvard T.H. Chan School of Public Health**
**2017 -** **Professor in the Department of Stem Cell and Regenerative Biology, Harvard Universit**

# Work experience[中文]

# Publication[English]

- Yagi M, Ji F, Charlton J, Cristea S, Messemer K, Horwitz N, Di Stefano B, Tsopoulidis N, Hoetker MS, Huebner AJ, Bar-Nur O, Almada AE, Yamamoto M, Patelunas A, Goldhamer DJ, Wagers AJ, **Michor F**, Meissner A, Sadreyev RI, Hochedlinger K. Dissecting dual roles of MyoD during lineage conversion to mature myocytes and myogenic stem cells. Genes Dev. 2021 Sep 01; 35(17-18):1209-1228. PMID: 34413137.
- Wu HJ, Landshammer A, Stamenova EK, Bolondi A, Kretzmer H, Meissner A, **Michor F**. Topological isolation of developmental regulators in mammalian genomes. Nat Commun. 2021 08 12; 12(1):4897. PMID: 34385432.
- Poels KE, Schoenfeld AJ, Makhnin A, Tobi Y, Wang Y, Frisco-Cabanos H, Chakrabarti S, Shi M, Napoli C, McDonald TO, Tan W, Hata A, Weinrich SL, Yu HA, **Michor F**. Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer. Nat Commun. 2021 06 17; 12(1):3697. PMID: 34140482.
- Janiszewska M, Stein S, Metzger Filho O, Eng J, Kingston NL, Harper NW, Rye IH, Aleckovic M, Trinh A, Murphy KC, Marangoni E, Cristea S, Oakes B, Winer EP, Krop IE, Russnes HG, Spellman PT, Bucher E, Hu Z, Chin K, Gray JW, **Michor F**, Polyak K. The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer. JCI Insight. 2021 Jun 08; 6(11). PMID: 33886505.
- Zee BM, Poels KE, Yao CH, Kawabata KC, Wu G, Duy C, Jacobus WD, Senior E, Endress JE, Jambhekar A, Lovitch SB, Ma J, Dhall A, Harris IS, Blanco MA, Sykes DB, Licht JD, Weinstock DM, Melnick A, Haigis MC, **Michor F**, Shi Y. Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia. iScience. 2021 Jun 25; 24(6):102651. PMID: 34151238.
- Filho OM, Viale G, Stein S, Trippa L, Yardley DA, Mayer IA, Abramson VG, Arteaga CL, Spring LM, Waks AG, Wrabel E, DeMeo MK, Bardia A, Dell'Orto P, Russo L, King TA, Polyak K, **Michor F**, Winer EP, Krop IE. Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab. Cancer Discov. 2021 May 03. PMID: 33941592.
- Shen YJ, Mishima Y, Shi J, Sklavenitis-Pistofidis R, Redd RA, Moschetta M, Manier S, Roccaro AM, Sacco A, Tai YT, **Mercier F**, Kawano Y, Su NK, Berrios B, Doench JG, Root DE, Michor F, Scadden DT, Ghobrial IM. Progression signature underlies clonal evolution and dissemination of multiple myeloma. Blood. 2021 Apr 29; 137(17):2360-2372. PMID: 33150374.
- Randles A, Wirsching HG, Dean JA, Cheng YK, Emerson S, Pattwell SS, Holland EC, **Michor F**. Computational modelling of perivascular-niche dynamics for the optimization of treatment schedules for glioblastoma. Nat Biomed Eng. 2021 04; 5(4):346-359. PMID: 33864039.
- Minussi DC, Nicholson MD, Ye H, Davis A, Wang K, Baker T, Tarabichi M, Sei E, Du H, Rabbani M, Peng C, Hu M, Bai S, Lin YW, Schalck A, Multani A, Ma J, McDonald TO, Casasent A, Barrera A, Chen H, Lim B, Arun B, Meric-Bernstam F, Van Loo P, **Michor F**, Navin NE. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature. 2021 04; 592(7853):302-308. PMID: 33762732.

# Publication[中文]

# Information Reference

-  homepage: https://www.hsph.harvard.edu/franziska-michor/
-  homepage: http://michorlab.dfci.harvard.edu/index.php/people/franziska-michor
-  googlescholar: https://scholar.google.com/citations?hl=zh-CN&user=2oXpzgQAAAAJ 
-  aminer: https://www.aminer.cn/profile/michor-franziska/5633c74945cedb339abf66c8

# Notes